Roberta Rizzo

Dr. Roberta Rizzo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Federica GiambòFederica Giambò
Federica Giambò
GLGian Marco Leone
Gian Marco Leone
Giuseppe GattusoGiuseppe Gattuso
Giuseppe Gattuso
RRRoberta Rizzo
Roberta Rizzo
ACAlessia Cosentino
Alessia Cosentino
Luca FalzoneLuca Falzone
Luca Falzone
Environmental or occupational exposure to pesticides is considered one of the main risk factors for the development of various diseases. Behind the development of pesticide-associated pathologies, there are both genetic and epigenetic alterations, where these latter are mainly represented by the alteration in the expression levels of microRNAs and by the change in the methylation status of the DNA. At present, no studies have comprehensively evaluated the genetic and epigenetic alterations induced by pesticides; therefore, the aim of the present study was to identify modifications in gene miRNA expression and DNA methylation useful for the prediction of pesticide exposure. For this purpose, an integrated analysis of gene expression, microRNA expression, and DNA methylation datasets obtained from the GEO DataSets database was performed to identify putative genes, microRNAs, and DNA methylation hotspots associated with pesticide exposure and responsible for the development of different diseases. In addition, DIANA-miRPath, STRING, and GO Panther prediction tools were used to establish the functional role of the putative biomarkers identified. The results obtained demonstrated that pesticides can modulate the expression levels of different genes and induce different epigenetic alterations in the expression levels of miRNAs and in the modulation of DNA methylation status.

10 August 2022 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
Giuseppe GattusoGiuseppe Gattuso
Giuseppe Gattuso
salvatore crimisalvatore crimi
salvatore crimi
Alessandro LavoroAlessandro Lavoro
Alessandro Lavoro
RRRoberta Rizzo
Roberta Rizzo
GMGiorgia Musumarra
Giorgia Musumarra
Luca FalzoneLuca Falzone
Luca Falzone
Oral cancer is one of the most common malignancies worldwide, accounting for 2% of all cases annually and 1.8% of all cancer deaths. To date, tissue biopsy and histopathological analyses are the gold standard methods for the diagnosis of oral cancers. However, oral cancer is generally diagnosed at advanced stages with a consequent poor 5-year survival (~50%) due to limited screening programs and inefficient physical examination strategies. To address these limitations, liquid biopsy is recently emerging as a novel minimally invasive tool for the early identification of tumors as well as for the evaluation of tumor heterogeneity and prognosis of patients. Several studies have demonstrated that liquid biopsy in oral cancer could be useful for the detection of circulating biomarkers including circulating tumor DNA (ctDNA), microRNAs (miRNAs), proteins, and exosomes, thus improving diagnostic strategies and paving the way to personalized medicine. However, the application of liquid biopsy in oral cancer is still limited and further studies are needed to better clarify its clinical impact. The present manuscript aims to provide an updated overview of the potential use of liquid biopsy as an additional tool for the management of oral lesions by describing the available methodologies and the most promising biomarkers.

9 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Giuseppe GattusoGiuseppe Gattuso
Giuseppe Gattuso
RRRoberta Rizzo
Roberta Rizzo
Alessandro LavoroAlessandro Lavoro
Alessandro Lavoro
VSVincenzoleo Spoto
Vincenzoleo Spoto
Giuseppe PorcielloGiuseppe Porciello
Giuseppe Porciello
Mario SalmeriMario Salmeri
Mario Salmeri
Legionella pneumophila (L. pneumophila) is one of the most threatening nosocomial pathogens. The implementation of novel and more effective surveillance and diagnostic strategies is mandatory to prevent the occurrence of legionellosis outbreaks in hospital environments. On these bases, the present review is aimed to describe the main clinical and molecular features of L. pneumophila focusing attention on the latest findings on drug resistance mechanisms. In addition, a detailed description of the current guidelines for the disinfection and surveillance of the water systems is also provided. Finally, the diagnostic strategies available for the detection of Legionella spp. were critically reviewed, paying the attention to the description of the culture, serological and molecular methods as well as on the novel high-sensitive nucleic acid amplification systems, such as droplet digital PCR.